Posted on October 9, 202510/9/25
Navigating the New HTA Landscape: Pamela Vo on Strategic Evidence Planning
Posted on October 1, 202510/1/25
Brave New Commercialization World: Reimagining Global Launch Strategies in Life Sciences
Posted on September 30, 20259/30/25
Strategic PICO Planning: Navigating Oncology Markets with NAVLIN by EVERSANA
Posted on September 30, 20259/30/25
Strategic PICO Planning: Enhancing Early-Phase Development for Market Access
Posted on August 25, 20258/25/25
Evaluation of HTA Frameworks for In Vivo Diagnostics: Assessing Methodological Gaps and Implications for Market Access
Posted on August 22, 20258/22/25
Navigating MFN: Alan Crowther on What Pharma Brands Must Know Now
Posted on July 22, 20257/22/25
Case Study: Transforming Market Access with NAVLIN Insights KPI
Posted on July 8, 20257/8/25
Navigating the Not-So-Direct Path to Access – A Pharmacist’s Perspective
Posted on May 23, 20255/23/25
Most Favored Nation Pricing | Insights and Implications for Manufacturers
Posted on April 11, 20254/11/25